Targeting glycolysis with 2-deoxy-d-glucose sensitizes primary cell cultures of renal cell carcinoma to tyrosine kinase inhibitors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00432-020-03278-8.pdf
Reference35 articles.
1. Akhtar M, Al-Bozom IA, Al Hussain T (2018) Molecular and metabolic basis of clear cell carcinoma of the kidney. Adv Anat Pathol 25:189–196
2. Akins NS, Nielson TC, Le HV (2018) Inhibition of glycolysis and glutaminolysis. An emerging drug discovery approach to combat cancer. Curr Top Med Chem 18:494–504
3. Albiges L et al (2019) Updated European Association of Urology guidelines on renal cell carcinoma. Immune checkpoint inhibition is the new backbone in first-line treatment of metastatic clear-cell renal cell carcinoma. Eur Urol 76:151–156
4. Angulo JC, Shapiro O (2019) The changing therapeutic landscape of metastatic renal cancer. Cancers 11:1227
5. Bianchi C et al (2010) Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3. Am J Pathol 176:1660–1670
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Salvia miltiorrhiza inhibited lung cancer through aerobic glycolysis suppression;Journal of Ethnopharmacology;2024-09
2. Metabolic alterations in hereditary and sporadic renal cell carcinoma;Nature Reviews Nephrology;2024-01-22
3. MicroRNA-142-3p promotes renal cell carcinoma progression by targeting RhoBTB3 to regulate HIF-1 signaling and GGT/GSH pathways;Scientific Reports;2023-04-12
4. SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent manner;Journal of Translational Medicine;2022-12-16
5. Molecular mechanisms of resistance to tyrosine kinase inhibitor in clear cell renal cell carcinoma;International Journal of Urology;2022-09-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3